Page 1 | Search Results | Hematology, ASH Education Program

1-12 of 12

Sort by

Sort Order Select

Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.

https://doi.org/10.1182/hematology.2019000370

Published: 2019

Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.

https://doi.org/10.1182/hematology.2019000017

Published: 2019

Journal Articles

Mechanisms of and approaches to overcoming resistance to immunotherapy

Liora Schultz, Rebecca Gardner

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 226–232.

https://doi.org/10.1182/hematology.2019000018

Published: 2019

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Are CAR T cells better than antibody or HCT therapy in B-ALL?

Michael A. Pulsipher

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 16–24.

https://doi.org/10.1182/asheducation-2018.1.16

Published: 2018

Journal Articles

Checkpoint inhibition and cellular immunotherapy in lymphoma

Premal Lulla, Helen E. Heslop

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 390–396.

https://doi.org/10.1182/asheducation-2016.1.390

Published: 2016

Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.

https://doi.org/10.1182/asheducation-2016.1.567

Published: 2016

Journal Articles

Advances in therapies for non-Hodgkin lymphoma in children

Rachel Kobos, William Terry

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 522–528.

https://doi.org/10.1182/asheducation.V2015.1.522.3916185

Published: 2015

Journal Articles

Chimeric antigen receptor T-cell therapy for ALL

Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 559–564.

https://doi.org/10.1182/asheducation-2014.1.559

Published: 2014

Journal Articles

T-cell adoptive immunotherapy for acute lymphoblastic leukemia

Terry J. Fry, Crystal L. Mackall

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 348–353.

https://doi.org/10.1182/asheducation-2013.1.348

Published: 2013

Journal Articles

Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen

Renier J. Brentjens, Kevin J. Curran

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 143–151.

https://doi.org/10.1182/asheducation.V2012.1.143.3798224

Published: 2012

Journal Articles

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

Dieter Hoelzer

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 243–249.

https://doi.org/10.1182/asheducation-2011.1.243

Published: 2011

NARROW

CAR T-cell therapy: is it prime time in myeloma?

Moving immunotherapy into the front line in ALL

Mechanisms of and approaches to overcoming resistance to immunotherapy

Antibody-based therapies in patients with acute lymphoblastic leukemia

Are CAR T cells better than antibody or HCT therapy in B-ALL?

Checkpoint inhibition and cellular immunotherapy in lymphoma

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Advances in therapies for non-Hodgkin lymphoma in children

Chimeric antigen receptor T-cell therapy for ALL

T-cell adoptive immunotherapy for acute lymphoblastic leukemia

Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only